BioSyent Inc (RX):企業の財務・戦略的SWOT分析

◆英語タイトル:BioSyent Inc (RX) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15055
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioSyent Inc (BioSyent), formerly Hedley Technologies Inc is a specialty pharmaceutical company that offers in-licensing or acquiring innovative pharmaceutical products and technologies to enhance human health. The company’s products include Aguettant System for pre-filled syringes, FeraMAX 150 an oral hematinic, Cathejell Jelly, FeraMAX powder a water soluble oral iron supplement, and RepaGyn a vaginal suppository. It also provides Proktis-M and Protect-It is a non-chemical taht is used as a preventative treatment against insect infestations in stored grains. BioSyent’ products are used for surface anesthesia and lubrication for procedures such as cystoscopies and other endourethral operations; prevention of iron deficiency anaemia, and treatment of vaginal mucosa and vaginal dryness. The company has its operations in Canada and the US. BioSyent is headquartered in Toronto, Ontario, Canada.

BioSyent Inc Key Recent Developments

Nov 21,2018: BioSyent releases results for third quarter and first nine months of 2018
Sep 10,2018: BioSyent announces changes to executive management
Aug 22,2018: BioSyent releases Q2 and H1 2018 results
May 30,2018: BioSyent Releases Results for Q1 2018
Mar 21,2018: BioSyent Releases Results for Fourth Quarter and Full Year 2017

This comprehensive SWOT profile of BioSyent Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of BioSyent Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

BioSyent Inc – Key Information
BioSyent Inc – Overview
BioSyent Inc – Key Employees
BioSyent Inc – Key Employee Biographies
BioSyent Inc – Key Operational Heads
BioSyent Inc – Major Products and Services
BioSyent Inc – History
BioSyent Inc – Company Statement
BioSyent Inc – Locations And Subsidiaries
BioSyent Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

BioSyent Inc – Business Description
BioSyent Inc – Corporate Strategy
BioSyent Inc – SWOT Analysis
SWOT Analysis – Overview
BioSyent Inc – Strengths
BioSyent Inc – Weaknesses
BioSyent Inc – Opportunities
BioSyent Inc – Threats
BioSyent Inc – Key Competitors

Section 3 – Company Financial Performance Charts

BioSyent Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

BioSyent Inc, Key Information
BioSyent Inc, Key Ratios
BioSyent Inc, Share Data
BioSyent Inc, Major Products and Services
BioSyent Inc, History
BioSyent Inc, Key Employees
BioSyent Inc, Key Employee Biographies
BioSyent Inc, Key Operational Heads
BioSyent Inc, Other Locations
BioSyent Inc, Subsidiaries
BioSyent Inc, Key Manufacturing facilities
BioSyent Inc, Key Competitors
BioSyent Inc, SWOT Analysis
BioSyent Inc, Ratios based on current share price
BioSyent Inc, Annual Ratios
BioSyent Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

BioSyent Inc, Performance Chart
BioSyent Inc, Ratio Charts

★海外企業調査レポート[BioSyent Inc (RX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NextEra Energy Resources LLC-エネルギー分野:企業M&A・提携分析
    Summary NextEra Energy Resources, LLC (NEER), a subsidiary of NextEra Energy, Inc., is a diversified clean energy company and is one of the largest wholesale generators of electric power in the US. The company, together with its subsidiaries owns, develops, constructs, manages and operates electrici …
  • Tennessee Valley Authority:企業の戦略・SWOT・財務情報
    Tennessee Valley Authority - Strategy, SWOT and Corporate Finance Report Summary Tennessee Valley Authority - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • The Jean Coutu Group (PJC) Inc.:企業の戦略・SWOT・財務分析
    The Jean Coutu Group (PJC) Inc. - Strategy, SWOT and Corporate Finance Report Summary The Jean Coutu Group (PJC) Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Kuala Lumpur Kepong Berhad (KLK):企業の財務・戦略的SWOT分析
    Kuala Lumpur Kepong Berhad (KLK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • 2-BBB Medicines BV:製薬・医療:M&Aディール及び事業提携情報
    Summary 2-BBB Medicines BV (2-BBB), formerly to-BBB Therapeutics BV is a biotechnology company that develops medicines for the treatment of brain cancer and neuro-inflammatory diseases. The company develops medicines using its proprietary liposomal drug delivery platform, G-Technology. Its pipeline …
  • Ecrins Therapeutics SAS-製薬・医療分野:企業M&A・提携分析
    Summary Ecrins Therapeutics SAS (Ecrins) is a biotechnology company that discovers and develops small molecule drug candidates against several oncology indications in humans and domestic animals. The company provides products such as native and labeled tubulin, tubulin polymerization kit and monoclo …
  • Sitara Chemical Industries Ltd (SITC):企業の財務・戦略的SWOT分析
    Sitara Chemical Industries Ltd (SITC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Penta-Ocean Construction Co Ltd:企業の戦略・SWOT・財務分析
    Penta-Ocean Construction Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Penta-Ocean Construction Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • University of South Florida-製薬・医療分野:企業M&A・提携分析
    Summary University of South Florida (USF) is an educational university that offers undergraduate, graduate, specialist and doctoral level degrees. The university offers degrees in various fields including accounting, advertising, Africana studies, American studies, anthropology, applied science, mar …
  • AstraZeneca Plc (AZN):医療機器:M&Aディール及び事業提携情報
    Summary AstraZeneca plc (AstraZeneca) is a biopharmaceutical company that endeavors to discover, produce and commercialize a wide range of prescription drugs. It focuses on therapy areas such as respiratory; cardiovascular and renal and metabolic diseases; and cancer, besides autoimmune, infection a …
  • Nottingham Building Society:企業の戦略・SWOT・財務情報
    Nottingham Building Society - Strategy, SWOT and Corporate Finance Report Summary Nottingham Building Society - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Rosoboronexport:戦略・SWOT・企業財務分析
    Rosoboronexport - Strategy, SWOT and Corporate Finance Report Summary Rosoboronexport - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Global Cardiovascular Innovation Center-医療機器分野:企業M&A・提携分析
    Summary Global Cardiovascular Innovation Center (GCIC) is a healthcare service provider that offers medical technology services. The organization designs, manufactures and distributes cardiovascular products and technologies. It has an incubator facility to help start up companies in developing adva …
  • Bank Leumi le-Israel B.M.:戦略・SWOT・企業財務分析
    Bank Leumi le-Israel B.M. - Strategy, SWOT and Corporate Finance Report Summary Bank Leumi le-Israel B.M. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Life Time Inc:企業の戦略的SWOT分析
    Life Time Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Boardriders, Inc:企業の戦略的SWOT分析
    Boardriders, Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Macy’s Inc:企業の戦略・SWOT・財務情報
    Macy's Inc - Strategy, SWOT and Corporate Finance Report Summary Macy's Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Atlas Genetics Ltd:企業の製品パイプライン分析2018
    Summary Atlas Genetics Ltd (Atlas Genetics) is an in vitro diagnostics company that offers decentralised, near-patient and point of care testing services. The company develops and offers diagnostic platforms such as io system and callisto system. Its io system is a diagnostic instrument and disposab …
  • Advanced Biological Laboratories SA-製薬・医療分野:企業M&A・提携分析
    Summary Advanced Biological Laboratories SA (ABL) is a healthcare information technology company that provides integrated software solutions for personalised medicine. The company’s products include improving disease management software, project management software, cumulative reporting and related …
  • EnCana Corp (ECA):企業の財務・戦略的SWOT分析
    EnCana Corp (ECA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆